![Lisa Bollinger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lisa Bollinger
No open positions remaining
Net worth: 741 $ as of 30/09/2026
Profile
Lisa L.
Bollinger worked at Amgen, Inc. as Vice President-Global Regulatory Affairs, R&D from 2018 to 2021.
From 2021 to 2024, worked at Merck & Co., Inc. as VP-Regulatory Affairs & Global Regulatory Affairs.
Served as Independent Director at Apogee Therapeutics, Inc. from 2024 to 2026.
Held the position of Chief Medical Officer at Polaryx Therapeutics, Inc. from 2025 to 2026.
Also worked at the Center for Drug Evaluation & Research as Associate Director-New Drug.
Education includes a doctorate from Uniformed Services University of the Health Sciences and an undergraduate degree from the University of California.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 27/07/2026 | 358 ( 0% ) | 741 $ | 30/09/2026 |
Former positions of Lisa Bollinger
| Companies | Position | End |
|---|---|---|
| APOE THERPAR | Director/Board Member | 03/09/2026 |
| POLARYX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 19/07/2026 |
| MERCK & CO., INC. | General Counsel | 01/05/2024 |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 01/03/2021 |
Center for Drug Evaluation & Research
 Center for Drug Evaluation & Research General GovernmentGovernment Operates agencies for the department of health and human services | Corporate Officer/Principal | - |
Education of Lisa Bollinger
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
70
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Uniformed Services University of the Health Sciences
 Uniformed Services University of the Health Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Center for Drug Evaluation & Research
Center for Drug Evaluation & Research General GovernmentGovernment Operates agencies for the department of health and human services | Government |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Polaryx Therapeutics, Inc.
 Polaryx Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that engages in discovery, development and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders | Commercial Services |
Apogee Therapeutics, Inc.
 Apogee Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops therapies for immunological and inflammatory disorders | Health Technology |
- Stock Market
- Insiders
- Lisa Bollinger
